We consider optimal design problems for dose-finding studies with censored Weibull time-to-event outcomes. Locally D-optimal designs are investigated for a quadratic dose-response model for log-transformed data subject to right censoring. Two-stage adaptive D-optimal designs using maximum likelihood estimation (MLE) model updating are explored through simulation for a range of different dose-response scenarios and different amounts of censoring in the model. The adaptive optimal designs are found to be nearly as efficient as the locally D-optimal designs. A popular equal allocation design can be highly inefficient when the amount of censored data is high and when the Weibull model hazard is increasing. The issues of sample size planning/ear...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
During the development process for new drugs, dose-finding trials have to be conducted and the choic...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
During the development process for new drugs, dose-finding trials have to be conducted and the choic...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
In dose-response studies with censored time-to-event outcomes, D-optimal designs depend on the true ...
During the development process for new drugs, dose-finding trials have to be conducted and the choic...